Business mix
- The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
- It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.
- GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Current key questions
- Can the company's products, services, or pipeline expand adoption within diagnostics & research?
- How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
- Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
